Development of Selective Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors-Reference-Cited by-同舟云学术

Development of Selective Pyrido[2,3-d]pyrimidin-7(8H)-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors

Published:2024-02-29 Issue:5 Volume:67 Page:3813-3842
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Rak Marcel¹²^ORCID,Menge Amelie¹²,Tesch Roberta¹²,Berger Lena M.¹²,Balourdas Dimitrios-Ilias¹²^ORCID,Shevchenko Ekaterina³,Krämer Andreas¹²⁴,Elson Lewis¹²,Berger Benedict-Tilman¹²^ORCID,Abdi Ismahan¹²,Wahl Laurenz M.¹²^ORCID,Poso Antti³⁵^ORCID,Kaiser Astrid¹,Hanke Thomas¹²^ORCID,Kronenberger Thales³⁵,Joerger Andreas C.¹²^ORCID,Müller Susanne¹²,Knapp Stefan¹²⁴^ORCID

Affiliation:

1. Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany

2. Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany

3. Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery (TüCAD2), Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany

4. German Translational Cancer Network (DKTK) and Frankfurt Cancer Institute (FCI), 60438 Frankfurt am Main, Germany

5. School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, 70210 Kuopio, Finland

Funder

Bundesministerium f?r Bildung und Forschung

Deutsche Forschungsgemeinschaft

Innovative Medicines Initiative

Horizon 2020 Framework Programme

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c02217

Reference82 articles.